Home / Products / Biosynthesis Chemicals / Enzyme Inhibitors / Monoamine oxidase (MAO) Inhibitors /

Monoamine oxidase (MAO) Inhibitors

Monoamine oxidase (MAO) inhibitors are a group of pharmaceutical drugs that play a crucial role in the treatment of various psychiatric and neurological disorders MAO inhibitors work by blocking the action of an enzyme called monoamine oxidase which is responsible for breaking down neurotransmitters such as serotonin dopamine and norepinephrine By inhibiting this enzyme MAO inhibitors increase the concentration of these neurotransmitters in the brain leading to improved mood and alleviation of symptoms associated with depression anxiety and other related conditions Our company offers a range of effective and reliable MAO inhibitors that have been extensively tested and proven to provide significant therapeutic benefits

Get A Quote
Products Application Supporting Data Resources Related Products


Catalog Number Chemical Name CAS # Price
EI-0626 Clorgyline hydrochloride 17780-75-5 Online Inquiry
EI-1015 Furazolidone 67-45-8 Online Inquiry
EI-1413 MAO-A/MAO-B Inhibitor 307548-94-3 Online Inquiry
EI-1676 Pargyline hydrochloride 306-07-0 Online Inquiry
EI-1860 Rasagiline mesylate 161735-79-1 Online Inquiry
EI-1937 Safinamide 133865-89-1 Online Inquiry


Monoamine oxidase (MAO) inhibitors have a wide range of applications in both medicine and neuroscience research In the field of medicine these inhibitors are primarily used as antidepressants specifically for the treatment of depression and anxiety disorders By inhibiting the activity of MAO enzymes which regulate the breakdown of neurotransmitters like serotonin and dopamine MAO inhibitors increase the levels of these neurotransmitters in the brain effectively improving mood and alleviating symptoms of depression

Aside from their therapeutic use MAO inhibitors also play a crucial role in neuroscience research They are commonly used to study the function of neurotransmitters and their role in various neurological disorders such as Parkinson's disease and Alzheimer's disease By inhibiting MAO activity researchers can better understand the impact of neurotransmitter dysregulation on these conditions and explore potential treatment strategies

Furthermore MAO inhibitors have demonstrated potential applications in the field of addiction treatment By inhibiting the breakdown of neurotransmitters involved in addiction pathways these inhibitors can help reduce cravings and withdrawal symptoms making them a valuable tool in substance abuse therapy

In summary the applications of MAO inhibitors extend to the treatment of depression and anxiety disorders as well as research on neurological disorders and addiction With their ability to modulate neurotransmitter levels MAO inhibitors hold great promise in improving mental health and advancing our understanding of the brain

Supporting Data


Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.


There is no product in your cart.